Gyrodyne LLC
GYRO
View Detailed Chart
8.794USD
+0.014+0.16%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
19.34MMarket Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+0.16%
5 Days
+0.50%
1 Month
-2.94%
6 Months
-11.26%
Year to Date
-2.51%
1 Year
-5.95%
View Detailed Chart
TradingKey Stock Score of Gyrodyne LLC
Currency: USD Updated: 2026-02-05Key Insights
Gyrodyne LLC's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 49 out of 53 in the Real Estate Operations industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Gyrodyne LLC's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Gyrodyne LLC Highlights
StrengthsRisks
Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center.
Growing
The company is in a growing phase, with the latest annual income totaling USD 4.95M.
No Dividend
The company hasn't paid dividends over the past 5 years.
Fairly Valued
The company’s latest PE is 0.00, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 913.43K shares, increasing 3.10% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Gyrodyne LLC News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Gyrodyne LLC Info
Gyrodyne, LLC owns and manages diverse commercial properties. The Company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Suffolk (Flowerfield) and Westchester (Cortlandt Manor) Counties, New York. The Company owns about a 63-acre site approximately 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, the Company owns about 13.8 acres inclusive of the 31,421-square-foot Cortlandt Medical Center.
Ticker SymbolGYRO
CompanyGyrodyne LLC
CEOFitlin (Gary Jay)
Websitehttps://www.gyrodyne.com/
Related Instruments
+1.48%
+2.54%
+0.60%
+5.02%
-0.12%
+1.19%
+4.11%
-0.21%
+2.10%
+3.41%
+3.22%
+0.03%
+1.01%
+7.68%
+2.36%
+3.43%
+1.57%
+0.13%
-0.26%
+2.61%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68550.800
-1419.330 (-2.03%)
282.580
+22.390 (+8.61%)
2016.000
-35.730 (-1.74%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
